Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan

Overview

Journal Int J Endocrinol Metab

Publisher Brieflands

Specialty Endocrinology

Date 2023 Jan 30

PMID 36714191

Authors

Anna Alieva

Anvar Alimov

Feruza Khaidarova

Saidiganikhoja Ismailov

Gulnara Rakhimova

Dilorom Nazhmutdinova

Barno Shagazatova

Victoria Tsareva

Affiliations

Soon will be listed here.

Abstract

Background: Type 2 diabetes (T2D) screening should be performed continuously at the primary care level in order to prevent disabling complications. Due to the high prevalence of undiagnosed T2D in the Republic of Uzbekistan, a decision was made to implement a nationwide screening program for T2D.

Objectives: The current study, taking into account the limited resources of Uzbekistan's health care system, aimed to offer the most effective, simple, and economical option required for the actual implementation of regular T2D screening in the country's primary care.

Methods: The screening was conducted from December 2018 to March 2019. There were four different scenarios, which differed in terms of eligibility criteria and the methodology adopted for detecting dysglycemia.

Results: A total of 2,430 patients were examined in four months. The T2D diagnosis was established by an endocrinologist in 9.3% of the cases with one eligibility criterion and 15.9% of the cases with three eligibility criteria. The diagnosis of T2D was established by an endocrinologist in 11.7% of the cases with HbA1c screening and 13.5% of the cases with glucose screening.

Conclusions: The screening was feasible in Uzbekistan only in limited conditions. The reasonable strategy was found to be the screening for incidental glycemia in all patients with at least one T2D risk factor. It was recommended that patients with incidental glycemia ≥ 7.8 mmol/L should be tested for fasting glycemia.

Citing Articles

Setting Ranges in Potential Biomarkers for Type 2 Diabetes Mellitus Patients Early Detection By Sex-An Approach with Machine Learning Algorithms.

Morgan-Benita J, Celaya-Padilla J, Luna-Garcia H, Galvan-Tejada C, Cruz M, Galvan-Tejada J Diagnostics (Basel). 2024; 14(15).

PMID: 39125499 PMC: 11311857. DOI: 10.3390/diagnostics14151623.

References

Moucheraud C, Lenz C, Latkovic M, Wirtz V . The costs of diabetes treatment in low- and middle-income countries: a systematic review. BMJ Glob Health. 2019; 4(1):e001258. PMC: 6407562. DOI: 10.1136/bmjgh-2018-001258. View

Hellgren M, Svensson A, Franzen S, Ericsson A, Gudbjornsdottir S, Ekstrom N . The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data. Diabetes Obes Metab. 2021; 23(7):1604-1613. PMC: 8360155. DOI: 10.1111/dom.14376. View

Jeon C, Murray M . Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008; 5(7):e152. PMC: 2459204. DOI: 10.1371/journal.pmed.0050152. View

Davidson K, Barry M, Mangione C, Cabana M, Caughey A, Davis E . Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA. 2021; 326(8):736-743. DOI: 10.1001/jama.2021.12531. View

Einarson T, Acs A, Ludwig C, Panton U . Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018; 17(1):83. PMC: 5994068. DOI: 10.1186/s12933-018-0728-6. View

Li Y, Jiang H, Cheng M, Yao W, Zhang H, Shi Y . Performance and costs of multiple screening strategies for type 2 diabetes: two population-based studies in Shanghai, China. BMJ Open Diabetes Res Care. 2020; 8(1). PMC: 7437878. DOI: 10.1136/bmjdrc-2020-001569. View

Meijnikman A, De Block C, Verrijken A, Mertens I, Corthouts B, Van Gaal L . Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score. J Diabetes Complications. 2016; 30(6):1043-9. DOI: 10.1016/j.jdiacomp.2016.05.004. View

Miranda J, Zaman M . Exporting 'failure': why research from rich countries may not benefit the developing world. Rev Saude Publica. 2010; 44(1):185-9. PMC: 2871307. DOI: 10.1590/s0034-89102010000100020. View

Keiffer M . Utilization of clinical practice guidelines: barriers and facilitators. Nurs Clin North Am. 2015; 50(2):327-45. DOI: 10.1016/j.cnur.2015.03.007. View

10.

Pereira Gray D, Evans P, Wright C, Langley P . The cost of diagnosing Type 2 diabetes mellitus by clinical opportunistic screening in general practice. Diabet Med. 2012; 29(7):863-8. DOI: 10.1111/j.1464-5491.2012.03607.x. View

11.

Al-Badri A, Hashmath Z, Oldland G, Miller R, Javaid K, Syed A . Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes. Diabetes Care. 2018; 41(9):2019-2025. PMC: 6105326. DOI: 10.2337/dc18-0324. View

12.

. 3. Prevention or Delay of Type 2 Diabetes: . Diabetes Care. 2020; 44(Suppl 1):S34-S39. DOI: 10.2337/dc21-S003. View

13.

Fischer F, Lange K, Klose K, Greiner W, Kraemer A . Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel). 2016; 4(3). PMC: 5041037. DOI: 10.3390/healthcare4030036. View

14.

Carey I, Critchley J, DeWilde S, Harris T, Hosking F, Cook D . Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study. Diabetes Care. 2018; 41(3):513-521. DOI: 10.2337/dc17-2131. View

15.

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2020; 44(Suppl 1):S15-S33. DOI: 10.2337/dc21-S002. View

16.

. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387(10027):1513-1530. PMC: 5081106. DOI: 10.1016/S0140-6736(16)00618-8. View

17.

Huebschmann A, Huxley R, Kohrt W, Zeitler P, Regensteiner J, Reusch J . Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019; 62(10):1761-1772. PMC: 7008947. DOI: 10.1007/s00125-019-4939-5. View

18.

Lee E . Diabetes: Screening, Diagnosis, and Prevention of Type 2 Diabetes. FP Essent. 2021; 504:16-21. View

19.

Kredo T, Abrams A, Young T, Louw Q, Volmink J, Daniels K . Primary care clinical practice guidelines in South Africa: qualitative study exploring perspectives of national stakeholders. BMC Health Serv Res. 2017; 17(1):608. PMC: 5575947. DOI: 10.1186/s12913-017-2546-z. View

20.

Olayemi E, Asare E, Benneh-Akwasi Kuma A . Guidelines in lower-middle income countries. Br J Haematol. 2017; 177(6):846-854. DOI: 10.1111/bjh.14583. View